Network News

Promega Plasmid Collection, available through Addgene, equips industry and academic researchers with powerful bioluminescent assays that provide deeper insights into endogenous cellular biology Watertown, MA USA. (July 15, 2025) Addgene, a purpose-driven organization helping scientists conduct experiments with greater ease, speed, and reproducibility, today announced a strategic partnership with Promega to expand Addgene’s vast plasmid repository with the […]

Boehringer Ingelheim Stiftung commits €7 million to support the EMBL Imaging Centre in Heidelberg A well-established EMBL partner, Boehringer Ingelheim Stiftung (BIS), is providing €7 million to continue the successful development of the EMBL Imaging Centre (IC). Since its inception, the highly committed staff have positioned the EMBL IC as an internationally leading institution for […]

WMT tests substances from the “Translational Trap” platform for antiviral and antisepsis effects in cellular assays and animal models Leipzig and Heidelberg, July 21, 2025 The German Federal Agency for Disruptive Innovations (SPRIN-D) and WMT AG in Heidelberg announced today that SPRIN-D has awarded WMT a research contract. WMT will test selected small molecule active […]

With its Proof of Concept grants, the European Research Council (ERC) supports scientists in further developing the economic potential of their research results. Two scientists from the German Cancer Research Center (DKFZ) have now received this coveted funding for the second time: Fabricio Loayza-Puch wants to identify unknown immunoactive peptides on tumor cells that can […]

NORTH CHICAGO, Ill. and NEW YORK, July 10, 2025 /PRNewswire/ — AbbVie (NYSE: ABBV) and IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation, Inc. (IGI), today announced an exclusive licensing agreement for IGI’s lead investigational asset, ISB 2001, developed using IGI’s proprietary BEAT® protein platform, for oncology and autoimmune diseases. “Multispecifics including trispecific antibodies represent a […]

Heidelberg, Germany / Paris, France, July 9th, 2025. BioMed X, an independent biomedical research institute based in Heidelberg, Germany, announced today the launch of a new initiative with Servier. The two partners will implement BioMed X’s proven XSeed Labs incubator model at Servier’s research and development site in Paris-Saclay. This new XSeed Labs – the first of its kind in Europe […]

Investing in a healthier future: The HORNBACH Group is supporting the new National Cancer Prevention Center in Heidelberg with a donation of five million euros. In the future, a new laboratory will conduct research into more effective early detection and screening methods. “Preventive research is a very important field for the future that deserves a […]

After a pilot last year, GeneNovate, Germany’s first national entrepreneurship program for gene and cell therapies, took place for the second time. All participants in the program met in Berlin on 26 June for the joint closing event. There, they presented a total of 23 research projects to a high-caliber jury of business angels, venture […]

Alzheimer’s disease is the most common type of dementia, and early detection is important for better treatment. This study looked at small RNA molecules in the blood to see if they could help identify early signs of Alzheimer’s, especially in people with high levels of amyloid, a key Alzheimer’s marker. Researchers analyzed blood samples from […]